Stocktoria
PRF Technologies Ltd. PRFX
PRF Technologies Ltd. (PRFX) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $17,000 at a -29541.2% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.159 |
| Retained earnings / assets | -5.108 |
| EBIT / assets | -0.427 |
| Equity / liabilities | 3.431 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| PRFX | PRF Technologies Ltd. | 4/9 | -14.88 | — | — |
| JUNS | JUPITER NEUROSCIENCES, INC. | 2/9 | — | — | — |
| GNLX | GENELUX Corp | 2/9 | — | — | — |
| ASBP | Aspire Biopharma Holdings, Inc. | 2/9 | — | — | — |
| TLPH | TALPHERA, INC. | 4/9 | — | — | — |
| TCRT | Alaunos Therapeutics, Inc. | 2/9 | — | — | — |
| IBO | IMPACT BIOMEDICAL INC. | 3/9 | -2.38 | — | — |
About PRF Technologies Ltd.
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.
FAQ
Is PRFX financially healthy?
PRF Technologies Ltd.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does PRFX pay a dividend?
No, PRF Technologies Ltd. does not currently pay a dividend.
How profitable is PRFX?
In FY2025, PRF Technologies Ltd. had a net margin of -29541.2% and a return on equity of -54.1%.
Is PRFX a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on PRF Technologies Ltd.: a Piotroski F-score of 4/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.